Skip to main content

Table 2 Summary of subgroup analysis for the pooled prevalence of treatment failure among HIV-infected children in Sub-Sahara Africa, 2009 to 2023 (n = 33)

From: Treatment failure among Sub-Sahara African children living with HIV: a systematic review and meta-analysis

Variables

Subgroup

Prevalence,% (95% CI, I2, P-value)

Country

Cameroon

39.41 (21.54–57.28, 96.10, < 0.01)

Ethiopia

13.77 (10.08–17.47, 94.9, < 0.01)

Nigeria

20.66 (12.44–28.88, 78.80, 0.009)

South Africa

16.81 (12.59–21.03, 96, < 0.01)

Tanzania

36.96 (24.15–49.77, 94.50, < 0.01)

Other

39.30 ( 29.91–48.69, 97.80, < 0.01)

Study design

Cross-sectional

34.76 (22.44–47.08, 98.60, < 0.01)

Cohort

20.82 (17.02–24.62, 97.70, < 0.01)

Publication year

2009–2015

27.87 (22.30–33.45, 97.90, < 0.01)

2016–2023

25.29 (18.25–32.33, 98.90, < 0.01)